Leicester
Centre
Cancer patients in Leicester have access to early phase oncology and haematology clinical trials through the Hope Cancer Trials Centre which is a dedicated cancer specific clinical area. It is the only such unit in the Midlands and attracts referrals from far afield. The Centre’s partnership with the Leicester NIHR...
London - Institute of Cancer Research and The Royal Marsden
Centre
The Institute of Cancer Research (ICR) and the Royal Marsden (RM) are committed to the accelerated and optimal development of rationally designed, novel anti-cancer drugs, through hypothesis-testing and biomarker-driven trials to ensure rapid drug approval and and maximal likelihood of patient benefit. The joint organisation is internationally at the forefront...
London - King's Health Partners
Centre
King’s Health Partners ECMC focuses particularly on new Molecular and Cellular cancer immunotherapies, building on recent translation of agents discovered in King’s laboratories. Examples, both leading to foundation of spin-out companies (Epsilogen, Leucid), include: A first-in-class IgE antibody, which demonstrated the safety of this highly novel therapeutic approach; CAR-T cell...
London - University College London
Centre
University College London (UCL) ECMC is committed to performing world-class clinical cancer research to discover and develop new treatments and improve the outcome for patients. Our Centre integrates fundamental scientific advances with optimised patient care in high quality clinical research performed in a patient focused environment. Our Centre has expertise...
Manchester
Centre
Manchester ECMC is leading the way in cancer research with an unwavering focus on offering the best treatment options to patients through precision medicine. Our work takes into consideration the complex genetics and evolution of cancer and how this affects the way in which an individual responds to treatments. This...
Newcastle
Centre
ECMC and CRUK Centre where the focus of research is the delivery of early phase trials in both adults and paediatric patients, with fully compliant dedicated early phase trials units and clinical pharmacology facilities. The ECMC has experience in multiple first-in-human studies, including small molecules, immunotherapy, novel antibodies and cellular...
Oxford
Centre
Individualising patient care is the goal of the Oxford ECMC. This means applying fundamental scientific discoveries in cancer biology to the development of novel cancer therapies and prognostic / diagnostic biomarkers. The Centre focuses on Early Phase trials, and works closely with a number of national and international collaborators from...
Southampton
Centre
Southampton ECMC is internationally recognised for its expertise in delivery of early phase cancer studies. The centre has a strong global reputation in the design and delivery of studies in lymphoid malignancies, urological tumours and immunotherapy. Embedded with trial delivery is a strong translational endpoint laboratory with a robust quality...
London - Imperial College London
Centre
The Imperial Experimental Cancer Medicine Centre is nationally and internationally known for developing cancer technologies and therapies. We have 19 clinical trials currently open. Our strengths and USPs include: Leading in discovery, translation and application of novel technologies in cancer trials including: imaging methods particularly PET, MRI and ultrasound in...
In action...Imaging Group
Basic page
The Imaging Group held an introductory course on the role of computed tomography and magnetic resonance imaging in clinical trials held jointly with the Research Nurse Network Group. The meeting was organised with the Wolfson Molecular Imaging Centre and the Christie Hospital and was aimed at nursing staff involved in...